ecosystem / companies / bioconnect
BioConnect logo

BioConnect

BioConnect is a Toronto company that replaces keycards and PINs with biometric access control — face, fingerprint and mobile authentication for data centres, banks, hospitals and critical infrastructure. Founded in 2010 by Rob Douglas, it has over 2,200 customers and was acquired by Gentex Corporation in November 2025.

CybersecurityTorontoFounded 2010bioconnect.com
2,200+customers worldwideBioConnect, about page, 2026
15MFortune 500 employees protectedBioConnect, homepage, 2026
Nov 2025acquired by Gentex Corporation (NASDAQ: GNTX)Gentex announcement via BioConnect, 2025-11-17
~60people, based in Liberty Village (dated stage figure)TechTO stage 2017-08-30

The people

Bianca LopesFounder · 2 TechTO talks
RD
Rob DouglasFounder & CEOprofile coming

What they build

BioConnect EnterpriseBiometric identity layer for an existing access control systemProduct page ↗
BioConnect IDMobile biometric authenticator for physical accessProduct page ↗
Arc readersArc Touch (fingerprint), Arc Vision and Arc Rex (facial authentication)Product page ↗

Open roles via the TechTO Job Board

No roles on the TechTO Job Board yet.

Hiring? Reach 70,000 Canadian tech readers through the weekly TechTO newsletter.

Post a role on jobs.techto.org ↗Or try their own careers page: bioconnect.com/careers ↗

Listings sync from jobs.techto.org — the only structured source. We don’t scrape career sites.

On the TechTO stage

Every talk is searchable — ask the archive about BioConnect

About

BioConnect sells a multi-modal authentication platform plus its own biometric readers, letting enterprises add biometric identity to access control systems they already own. It was the first to bring a biometric mobile authenticator to market for physical access. In November 2025 Gentex Corporation (NASDAQ: GNTX), best known for automotive electronics, acquired the company; founder and CEO Rob Douglas now leads Gentex's Security & Access Control team, formed by combining BioConnect with EyeLock, an iris biometrics business Gentex obtained through its purchase of VOXX International. Bianca Lopes took the TechTO stage for BioConnect twice, in 2016 as VP of strategic marketing and global partnerships and in 2017 as chief identity officer.

Backers

Now owned by Gentex Corporation (NASDAQ: GNTX) following the November 2025 acquisition. Earlier backers are not confirmed here; BDC Capital provided $2M in 2020 to retain technical staff during the pandemic.

Some figures are founder-stated, not independently confirmed

Quick answers

What does BioConnect do?

Biometric access control. Its platform and Arc readers let enterprises secure doors and spaces with face, fingerprint or mobile authentication instead of keycards and PINs, layered onto access control systems they already have.

Who founded BioConnect?

Rob Douglas, in Toronto in 2010. He is still CEO and now also leads Gentex's Security & Access Control team.

What happened to BioConnect?

Gentex Corporation acquired it in November 2025. BioConnect continues to operate under its own name and its founder's leadership, combined with Gentex's EyeLock iris biometrics business.

Suggest an editWork here? Claim this page
Maintained by TechTO · facts sourced and dated · last reviewed Jul 15, 2026